Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
The paracrine influence of prostatic stroma on the proliferation of prostatic epithelial cells was investigated. Stromal cells from the human prostate have previously been shown to inhibit anchorage-dependent as well as anchorage-independent growth of the prostatic tumour epithelial cell lines PC-3 and LNCaP. Antiproliferative activity, mediated by a diffusible factor in the stromal cell conditioned medium, was found to be produced specifically by prostatic stromal cells. In the present study the characteristics of this factor were examined. It is demonstrated that prostate stroma-derived inhibiting factor is an acid- and heat-labile, dithiothreitol-sensitive protein. Although some similarities with type beta transforming growth factor (TGF-beta)-like inhibitors are apparent, evidence is presented that the factor is not identical to TGF-beta or to the TGF-beta-like factors activin and inhibin. Absence of TGF-beta activity was shown by the lack of inhibitory response of the TGF-beta-sensitive mink lung cell line CCL-64 to prostate stromal cell conditioned medium and to concentrated, partially purified preparations of the inhibitor. Furthermore, neutralising antibodies against TGF-beta 1 or TGF-beta 2 did not cause a decline in the level of PC-3 growth inhibition caused by partially purified inhibitor. Using Northern blot analyses, we excluded the involvement of inhibin or activin. It is concluded that the prostate stroma-derived factor may be a novel growth inhibitor different from any of the currently described inhibiting factors.
Kooistra
A
A
Department of Urology, Erasmus University/Academic Hospital Dijkzigt, Rotterdam, The Netherlands.
van den Eijnden-van Raaij
A J
AJ
Klaij
I A
IA
Romijn
J C
JC
Schröder
F H
FH
D000906:Antibodies / Q000494:pharmacology; D015152:Blotting, Northern; D002450:Cell Communication / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D003470:Culture Media; D004847:Epithelial Cells; D006131:Growth Inhibitors / Q000096:biosynthesis / Q000494:pharmacology / Q000502:physiology*; D006801:Humans; D008297:Male; D009500:Neutralization Tests; D011467:Prostate / Q000166:cytology* / Q000378:metabolism*; D011470:Prostatic Hyperplasia / Q000473:pathology; D011471:Prostatic Neoplasms / Q000473:pathology; D017154:Stromal Cells / Q000166:cytology / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000276:immunology / Q000502:physiology*; D014407:Tumor Cells, Cultured
D000906:Antibodies; D003470:Culture Media; D006131:Growth Inhibitors; D016212:Transforming Growth Factor beta